Skip to main content
An official website of the United States government

Grantee Details

The participating institutions include U01 grants to Research Units (PAR-21-334) and a U24 grant to the Management and Data Coordination Unit (PAR-21-335).

PI Name Sort descending PI Organization Title Grant Number Program Official
Giles, Erin

University Of Michigan At Ann Arbor
United States

Obesity, body fat distribution, and breast cancer risk: is visceral fat the culprit after menopause? 5R01CA269726-02 Marjorie Perloff, M.D.
Gill, Brian John Andrew

Columbia University Health Sciences
United States

The Impact of Local and Reversible Change to GABAergic Inhibitory Signaling on Tumor-Induced Cortical Dysfunction in Glioma 1R01NS140658-01A1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Gill, Brian John Andrew

Columbia University Health Sciences
United States

The Impact of Local and Reversible Change to GABAergic Inhibitory Signaling on Tumor-Induced Cortical Dysfunction in Glioma 1R01NS140658-01A1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Godwin, Andrew K.

University Of Kansas Medical Center
United States

Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem 5R01CA260132-05 Matthew Young, Ph.D.
Goel, Ajay

Beckman Research Institute/City Of Hope
United States

Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer 3U01CA214254-08S2 Matthew Young, Ph.D.
Goel, Ajay

Beckman Research Institute/City Of Hope
United States

5mC and 5hmC DNA alterations as sensitive and specific biomarkers for the non-invasive early detection of pancreatic ductal adenocarcinoma 1U01CA296639-01A1 Claire Zhu, Ph.D.
Goel, Ajay

Beckman Research Institute/City Of Hope
United States

Exosomal biomarkers for the early detection of hepatocellular carcinoma 5R01CA271443-03 Matthew Young, Ph.D.
Goggins, Michael G.

Johns Hopkins University
United States

Using markers to improve pancreatic cancer screening and surveillance: a multi-center study 5U01CA210170-09 Matthew Young, Ph.D.
Goncalves, Marcus Dasilva

New York University School Of Medicine
United States

Molecular Mechanisms of Fructose-induced Colorectal Cancer Cell Survival 5R01CA258697-05 Amit Kumar, Ph.D.
Gonzalez, Brian D

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Impact of Targeted Therapy on Cancer-Related Cognitive Impairment 5R01CA287666-02 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Gonzalez, Brian D

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Impact of Targeted Therapy on Cancer-Related Cognitive Impairment 5R01CA287666-02 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Goode, Diana J

University Of New England
United States

Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy 5R01CA267554-04 Rachel Altshuler, Ph.D.
Goode, Diana J

University Of New England
United States

Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy 5R01CA267554-04 Rachel Altshuler, Ph.D.
Grady, William Mallory

Fred Hutchinson Cancer Center
United States

Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome 3U54CA274374-04S2 Christos Patriotis, Ph.D., M.Sc.
Grady, William Mallory

Fred Hutchinson Cancer Center
United States

Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus 5U2CCA271902-04 Matthew Young, Ph.D.